Pulmonary Congestion
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Congestion trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Congestion trials you may qualify forBackground: Intravenous (IV) loop-diuretics have been a key component in treating pulmonary edema since the nineteen sixties and has a Class 1 recommendation i…
This investigator-initiated, prospective, randomized, blinded, multi-center, controlled trial will investigate the effect of a restrictive vs. liberal oxygenati…
This study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main g…
The heart is a pump that must both fill and empty effectively to move blood; if it cannot move enough, heart failure may ensue. Approximately half of all adults…
The human immune system is designed to protect individuals from external sources of infection and internal cell mutation. It works effectively and efficiently u…
A single-center prospective observational study will be conducted with the aim of determining the prevalence of venous congestion during ARDS using venous Doppl…
The primary objective of this study is to learn whether a morning dose of extended-release torsemide enhances renal sodium excretion after lunch (4-8 hours afte…
The main objective is to assess the effect of increased PEEP on echo-Doppler venous congestion in ARDS patients at two PEEP levels, by grading congestion in eac…